Sesma, A.; Pardo, J.; Isla, D.; M. Gálvez, E.; Gascón-Ruiz, M.; MartÃnez-Lostao, L.; Moratiel, A.; Paño-Pardo, J.R.; QuÃlez, E.; Torres-Ramón, I.;
et al. Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer. Cancers 2024, 16, 2798.
https://doi.org/10.3390/cancers16162798
AMA Style
Sesma A, Pardo J, Isla D, M. Gálvez E, Gascón-Ruiz M, MartÃnez-Lostao L, Moratiel A, Paño-Pardo JR, QuÃlez E, Torres-Ramón I,
et al. Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer. Cancers. 2024; 16(16):2798.
https://doi.org/10.3390/cancers16162798
Chicago/Turabian Style
Sesma, Andrea, Julian Pardo, Dolores Isla, Eva M. Gálvez, Marta Gascón-Ruiz, Luis MartÃnez-Lostao, Alba Moratiel, J. Ramón Paño-Pardo, Elisa QuÃlez, Irene Torres-Ramón,
and et al. 2024. "Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer" Cancers 16, no. 16: 2798.
https://doi.org/10.3390/cancers16162798
APA Style
Sesma, A., Pardo, J., Isla, D., M. Gálvez, E., Gascón-Ruiz, M., MartÃnez-Lostao, L., Moratiel, A., Paño-Pardo, J. R., QuÃlez, E., Torres-Ramón, I., Yubero, A., Zapata-GarcÃa, M., Domingo, M. P., Esteban, P., Sanz Pamplona, R., Lastra, R., & RamÃrez-Labrada, A.
(2024). Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer. Cancers, 16(16), 2798.
https://doi.org/10.3390/cancers16162798
